Daily RNS Catalyst Report
Date: 22 September 2025 | Generated by Catalyst-AI v2.5
Full Analysis Index
Catalyst Summary
Bullish Catalysts
Full Company Analysis
The primary catalyst is the new capacity reservation agreement with RWE for 150MW of its NEPTUNE V units. This is a positive operational milestone that signals repeat business and confidence from a major industrial partner. The agreement builds on an existing relationship, providing a degree of validation for ITM's technology and delivery capability. However, the market reaction may be tempered by the fact that these are reservations with call-offs expected by 2027, not yet firm orders, leaving some uncertainty on the exact timing and conversion. The stock is technically positive (Score: 4), suggesting the news arrives into a period of strengthening momentum.
Four Pillar Analysis
Positive momentum demonstrated by the 150MW capacity reservation agreement with a key existing partner, RWE.
The agreement validates the commercial traction of the new NEPTUNE V platform, a key part of the company's strategic product roadmap.
The deal operates within a supportive landscape for green hydrogen projects, but is not directly driven by a specific new policy.
While not a firm order, the reservation enhances future revenue visibility and strengthens market confidence in the company's order pipeline.
Technicals
Technically positive (Score: 4). The stock is trading slightly above its 200-day SMA (0.43%) and has shown recent strength with an 11.7% gain over the last 5 days. The RSI at 61.5 is strengthening but not yet overbought, indicating positive momentum.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- ITM Power enters into a capacity reservation agreement with RWE for 150MW of NEPTUNE V units.
 - This is equivalent to 30 units, with call-offs foreseen by 2027.
 - The agreement builds on an existing partnership, including the GetH2 Nukleus project.
 
This announcement is a minor positive execution milestone, confirming the start of the previously announced PRIMED programme. The involvement of Jaguar Land Rover and Oxford University as strategic support adds credibility but does not represent a firm commercial commitment. The core value driver for Ilika remains the successful scaling and commercialisation of its Goliath battery technology, and this is a small, incremental step on that path. The stock is technically neutral (Score: 0), trading significantly below its 52-week high, and this news is unlikely to be a major catalyst for a trend reversal.
Four Pillar Analysis
No new commercial agreements. The programme involves strategic support from JLR, which is a positive signal but not a contract.
The commencement of the PRIMED programme is an on-track execution milestone, progressing the company's strategy to commercialise its Goliath technology.
The programme is supported by the Advanced Propulsion Centre UK (APC), highlighting alignment with UK industrial strategy for battery technology.
Sentiment remains weak given the stock's performance. This news provides a minor positive data point but is unlikely to shift broader market sentiment significantly.
Technicals
Technically neutral (Score: 0). The stock is trading just above its 200-day SMA (0.03%) but remains significantly below its 52-week high (-25.5%). The RSI at 52 is neutral, suggesting a lack of strong directional momentum.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Ilika commences its PRIMED solid-state battery programme.
 - Jaguar Land Rover and Oxford University are providing strategic steering support.
 - The programme aims to scale up 50Ah battery production at UKBIC.
 
Elixirr has released two significant announcements: strong interim results and the acquisition of TRC Advisory. The primary catalyst is the exceptional financial performance detailed in the interim results, with 35% revenue growth (17% organic) and a 42% increase in adjusted EBITDA, significantly outperforming a weak consulting market. This is further bolstered by the simultaneous announcement of the strategic, immediately earnings-enhancing acquisition of TRC Advisory. The combination of a significant earnings beat and an accretive acquisition represents a powerful positive catalyst. However, the stock is technically overbought (RSI: 82.4) after a strong run, which has tempered the final score. The aggregate analysis points to a very strong positive market reaction, reflecting the dual catalysts of exceptional organic growth and strategic expansion.
Four Pillar Analysis
Exceptional momentum, with a 78% growth in cross-sell revenue and an increase in £1m+ clients from 22 to 31.
The acquisition of TRC Advisory is a major strategic step, significantly scaling the US presence and adding new capabilities, aligning with the company's M&A-led growth strategy.
The successful transition from AIM to the Main Market enhances the company's profile and access to capital, a positive strategic move.
Extremely strong financial results, with significant beats on revenue and profit metrics. The acquisition is immediately earnings-enhancing, which should be very well-received by the market.
Technicals
Technically strong (Score: 11). The stock is in a powerful uptrend, trading near its 52-week high with significant price gains across all timeframes. The RSI at 82.4 is deeply in overbought territory, which signals strong momentum but also raises the risk of a short-term pullback.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Revenue increased 35% to £71.4m (17% organic growth).
 - Adjusted EBITDA rose 42% to £21.5m, with margin expansion to 30.0%.
 - Acquired US strategy firm TRC Advisory for up to US$125m.
 - TRC acquisition is expected to be immediately earnings-enhancing.
 
The primary catalyst is a profit warning, with the company stating that full-year trading and profitability are expected to be materially below market expectations. This is a significant negative event, driven by a failure of the expected improvement in trading conditions to materialise. While the company points to a strong order book, the market's immediate focus will be on the sharp deterioration in the current year's forecast. The stock is already technically weak (Score: -4) and deeply oversold (RSI: 13), which provides a minor cushion (QCM-M2 triggered), but the negative sentiment from a profit warning is the dominant factor and is expected to drive the share price lower.
Four Pillar Analysis
Momentum is weak. Despite a growing order book (£47.3m), the company explicitly states that contract starts are being delayed.
The company's operational performance is challenged by the external environment, with the expected improvement in core sectors yet to materialise.
Delays are partly attributed to Building Safety Act ('BSA') approvals, indicating a negative impact from the current regulatory environment on project timelines.
Sentiment is now firmly negative due to the profit warning. The market will likely discount the positive medium-term outlook until tangible signs of a recovery in trading emerge.
Technicals
Technically weak (Score: -4). The stock is in a severe downtrend, having fallen 19.5% in the last 5 days and trading 25.3% below its 250-day high. The RSI of 13 indicates the stock is deeply oversold, which could lead to a short-term bounce, but the overall trend is firmly negative.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Full year trading and profitability for FY26 expected to be materially below market expectations.
 - Challenging trading conditions have continued into the new financial year.
 - Delays are attributed to spending constraints and Building Safety Act approvals.
 - Order book remains strong at £47.3m as of 31 July 2025.
 
Daily RNS Catalyst Report
Date: 22 September 2025 | Generated by runprofits.com
Full Analysis Index
Catalyst Summary
Bullish Catalysts
Full Company Analysis
The primary catalyst is the new capacity reservation agreement with RWE for 150MW of its NEPTUNE V units. This is a positive operational milestone that signals repeat business and confidence from a major industrial partner. The agreement builds on an existing relationship, providing a degree of validation for ITM's technology and delivery capability. However, the market reaction may be tempered by the fact that these are reservations with call-offs expected by 2027, not yet firm orders, leaving some uncertainty on the exact timing and conversion. The stock is technically neutral (Score: 4), trading just above its 200-day SMA, suggesting the news arrives without strong pre-existing momentum.
Four Pillar Analysis
Positive momentum demonstrated by the 150MW capacity reservation agreement with a key existing partner, RWE.
The agreement validates the commercial traction of the new NEPTUNE V platform, a key part of the company's strategic product roadmap.
The deal operates within a supportive landscape for green hydrogen projects, but is not directly driven by a specific new policy.
While not a firm order, the reservation enhances future revenue visibility and strengthens market confidence in the company's order pipeline.
Technicals
Technically positive (Score: 4). The stock is trading slightly above its 200-day SMA (0.43%) but has shown recent strength with a 13.5% gain over the last 5 days. The RSI at 58.9 is neutral, indicating no immediate overbought or oversold pressure.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- ITM Power enters into a capacity reservation agreement with RWE for 150MW of NEPTUNE V units.
 - This is equivalent to 30 units, with call-offs foreseen by 2027.
 - The agreement builds on an existing partnership, including the GetH2 Nukleus project.
 
This announcement is a minor positive execution milestone, confirming the start of the previously announced PRIMED programme. The involvement of Jaguar Land Rover and Oxford University as strategic support adds credibility but does not represent a firm commercial commitment. The core value driver for Ilika remains the successful scaling and commercialisation of its Goliath battery technology, and this is a small, incremental step on that path. The stock is technically weak (Score: -1), trading significantly below its 52-week high, and this news is unlikely to be a major catalyst for a trend reversal.
Four Pillar Analysis
No new commercial agreements. The programme involves strategic support from JLR, which is a positive signal but not a contract.
The commencement of the PRIMED programme is an on-track execution milestone, progressing the company's strategy to commercialise its Goliath technology.
The programme is supported by the Advanced Propulsion Centre UK (APC), highlighting alignment with UK industrial strategy for battery technology.
Sentiment remains weak given the stock's performance. This news provides a minor positive data point but is unlikely to shift broader market sentiment significantly.
Technicals
Technically weak (Score: -1). The stock is in a long-term downtrend, trading 29.4% below its 250-day high. Recent price action is flat, and the RSI at 38.4 is weak but not oversold. The technical picture suggests a lack of positive momentum.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Ilika commences its PRIMED solid-state battery programme.
 - Jaguar Land Rover and Oxford University are providing strategic steering support.
 - The programme aims to scale up 50Ah battery production at UKBIC.
 
Elixirr has released two significant announcements: strong interim results and the acquisition of TRC Advisory. The primary catalyst is the exceptional financial performance detailed in the interim results, with 35% revenue growth (17% organic) and a 42% increase in adjusted EBITDA, significantly outperforming a weak consulting market. This demonstrates strong underlying momentum and successful integration of past acquisitions. This is further bolstered by the simultaneous announcement of the acquisition of TRC Advisory, a fast-growing US consultancy. This move adds scale, enhances US presence, and is expected to be immediately earnings-enhancing. The combination of a significant earnings beat and a strategic, accretive acquisition represents a powerful positive catalyst. The stock's strong technicals (Score: 10) and high peer surprise score (1.5) confirm the market is likely to view this dual announcement very favourably.
Four Pillar Analysis
Exceptional momentum, with a 78% growth in cross-sell revenue and an increase in £1m+ clients from 22 to 31.
The acquisition of TRC Advisory is a major strategic step, significantly scaling the US presence and adding new capabilities, aligning with the company's M&A-led growth strategy.
The successful transition from AIM to the Main Market enhances the company's profile and access to capital, a positive strategic move.
Extremely strong financial results, with significant beats on revenue and profit metrics. The acquisition is immediately earnings-enhancing, which should be very well-received by the market.
Technicals
Technically strong (Score: 10). The stock is in a clear uptrend, trading near its 52-week high and showing strong momentum with a 14% gain over the last 10 days. The RSI at 80 is in overbought territory, which could temper the immediate upside, but the overall technical picture is very positive.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Revenue increased 35% to £71.4m (17% organic growth).
 - Adjusted EBITDA rose 42% to £21.5m, with margin expansion to 30.0%.
 - Acquired US strategy firm TRC Advisory for up to US$125m.
 - TRC acquisition is expected to be immediately earnings-enhancing.
 
The primary catalyst is a profit warning, with the company stating that full-year trading and profitability are expected to be materially below market expectations. This is a significant negative event, driven by a failure of the expected improvement in trading conditions to materialise, citing spending constraints and project delays. While the company points to a strong order book (£47.3m) and a positive medium-term outlook, the market's immediate focus will be on the sharp deterioration in the current year's forecast. The stock is already technically weak (Score: -1) and oversold (RSI: 22.1), which may provide some cushion (QCM-M2 triggered), but the negative sentiment from a profit warning typically overrides technical factors in the short term.
Four Pillar Analysis
Momentum is weak. Despite a growing order book (£47.3m), the company explicitly states that contract starts are being delayed.
The company's operational performance is challenged by the external environment, with the expected improvement in core sectors yet to materialise.
Delays are partly attributed to Building Safety Act ('BSA') approvals, indicating a negative impact from the current regulatory environment on project timelines.
Sentiment is now firmly negative due to the profit warning. The market will likely discount the positive medium-term outlook until tangible signs of a recovery in trading emerge.
Technicals
Technically weak (Score: -1). The stock is in a clear downtrend, trading 16.3% below its 250-day high. The RSI of 22.1 indicates the stock is in oversold territory, which could lead to a short-term bounce, but the overall trend remains negative.
Key Metrics
INDICATORS
PRICE RELATIVE TO MOVING AVERAGES
KEY METRICS
Key Points from RNS
- Full year trading and profitability for FY26 expected to be materially below market expectations.
 - Challenging trading conditions have continued into the new financial year.
 - Delays are attributed to spending constraints and Building Safety Act approvals.
 - Order book remains strong at £47.3m as of 31 July 2025.
 
